{"transactions":[{"id":1179907,"issuer":{"id":7863,"kind":"organization","name":"SeaStar Medical Holding Corp"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-04-03T23:33:07.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ICU common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs reported herein will vest in equal installments on the first, second and third anniversaries of April 1, 2025."}],"balance_after":15000,"derivative":{"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001213900-25-028747","document":"marketforms-69089.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831868/000121390025028747/marketforms-69089.xml","form_type":"4"}},{"id":1411905,"issuer":{"id":7863,"kind":"organization","name":"SeaStar Medical Holding Corp"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-09-09T22:24:17.000Z","date":"2024-08-30","kind":"grant","planned":false,"acquired":true,"shares":8100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents a grant of fully vested shares of the Issuer's common stock."}],"balance_after":10323,"source":{"system":"sec-edgar","filing":"0001213900-24-077008","document":"marketforms-66986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1831868/000121390024077008/marketforms-66986.xml","form_type":"4"}},{"id":1411904,"issuer":{"id":7863,"kind":"organization","name":"SeaStar Medical Holding Corp"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-09-09T22:24:17.000Z","date":"2024-04-18","kind":"grant","planned":false,"acquired":true,"shares":2223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of fully vested shares of the Issuer's common stock on a post reverse split basis. The original grant was for 55,556 shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of shares of common stock issued to the Reporting Person as of April 18, 2024 on a post-split basis."}],"balance_after":2223,"source":{"system":"sec-edgar","filing":"0001213900-24-077008","document":"marketforms-66986.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831868/000121390024077008/marketforms-66986.xml","form_type":"4"}},{"id":1411903,"issuer":{"id":7863,"kind":"organization","name":"SeaStar Medical Holding Corp"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-09-09T22:23:30.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On April 16, 2024, a Form 4 (the \"Original Report\") was filed on behalf of the Reporting Person which inadvertently overstated the number of restricted stock unites (\"RSUs\") reported in Column 4 and Column 5 of Table I due to an administrative error. This Form 4 amendment is being filed to correct the aggregate number of RSUs issued to the Reporting Person as of the original transaction date from 30,100 RSUs (752,500 pre reverse split) to 18,000 RSUs (450,000 pre reverse split), and to report the grant of such RSUs on Table II, instead of Table I as set forth on the Original Report."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F3","text":"On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date. Twenty-five percent (25%) of the RSUs will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the RSUs will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date. Twenty-five percent (25%) of the RSUs will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the RSUs will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"On June 7, 2024, the Issuer effectuated a 1-for-25 reverse split of the Issuer's common stock. This amount represents the number of RSUs granted to the Reporting Person as of April 12, 2024 on a post-split basis."}],"balance_after":18000,"derivative":{"underlying":"Common Stock, par value $0.0001 per share","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001213900-24-077007","document":"marketforms-66983.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831868/000121390024077007/marketforms-66983.xml","form_type":"4/A","original_submission_date":"2024-09-16"}},{"id":1541296,"issuer":{"id":7863,"kind":"organization","name":"SeaStar Medical Holding Corp"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2024-04-16T23:05:23.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":752500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock underlying restricted stock units (\"RSUs\") awarded to the Reporting Person. All shares reported herein will vest, subject to continued service, on the first anniversary of Mr. Green's appointment date.  Twenty-five percent (25%) of the shares will vest upon completion of one (1) year of service measured from January 10, 2024, and the remaining seventy-five percent (75%) of the shares will vest in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from January 10, 2025."}],"balance_after":752500,"source":{"system":"sec-edgar","filing":"0000929638-24-001502","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1831868/000092963824001502/form4.xml","form_type":"4"}},{"id":3111501,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option Grant","published_at":"2020-06-12T17:46:28.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vests on June 7, 2021, with an additional 6.25% of the total shares vesting quarterly thereafter, subject to continued service through each vesting date until June 7, 2024."}],"balance_after":100000,"derivative":{"exercise_price":1.45,"expiration_date":"2030-06-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001654954-20-006585","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000165495420006585/section16.xml","form_type":"4"}},{"id":3111500,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-12T17:46:28.000Z","date":"2020-06-08","kind":"grant","acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares. 25% vests on June 7, 2021, with an additional 6.25% of the total shares vesting quarterly thereafter, subject to continued service through each vesting date until June 7, 2024"}],"balance_after":521250,"source":{"system":"sec-edgar","filing":"0001654954-20-006585","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000165495420006585/section16.xml","form_type":"4"}},{"id":3653315,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-15T16:45:40.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":1500,"price":1.035,"value":1552.5,"ownership":{"direct":true},"balance_after":271250,"source":{"system":"sec-edgar","filing":"0001654954-19-001667","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000165495419001667/section16.xml","form_type":"4"}},{"id":3653314,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-15T16:45:40.000Z","date":"2019-02-13","kind":"grant","acquired":true,"shares":3500,"price":1.039,"value":3636.5,"ownership":{"direct":true},"balance_after":269750,"source":{"system":"sec-edgar","filing":"0001654954-19-001667","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000165495419001667/section16.xml","form_type":"4"}},{"id":3718805,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-26T16:00:33.000Z","date":"2018-12-21","kind":"sale","acquired":false,"shares":3330,"price":0.8141,"value":2710.953,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes post-split restricted shares previously issued."}],"balance_after":266250,"source":{"system":"sec-edgar","filing":"0001213900-18-017852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000121390018017852/ownership.xml","form_type":"4"}},{"id":3782194,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-26T19:55:57.000Z","date":"2018-10-24","kind":"grant","acquired":true,"shares":262500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares which vest on October 24, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Aggregate amount indicated reflects 20-for-1 reverse split and includes additional 3,750 post-split restricted shares previously issued."}],"balance_after":269580,"source":{"system":"sec-edgar","filing":"0001213900-18-014537","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000121390018014537/ownership.xml","form_type":"4"}},{"id":4007677,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Warrants","published_at":"2018-03-07T16:38:00.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":66600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Warrants were issued as part of units with the shares of common stock."}],"balance_after":66600,"derivative":{"exercise_price":0.54,"exercise_date":"2018-03-06","expiration_date":"2023-03-06","underlying":"Common Stock","underlying_shares":66600},"source":{"system":"sec-edgar","filing":"0001213900-18-002656","document":"f4030618green_aytubio.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000121390018002656/f4030618green_aytubio.xml","form_type":"4"}},{"id":4007676,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-07T16:38:00.000Z","date":"2018-03-06","kind":"purchase","acquired":true,"shares":66600,"price":0.45,"value":29970.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 75,000  restricted shares."}],"balance_after":141600,"source":{"system":"sec-edgar","filing":"0001213900-18-002656","document":"f4030618green_aytubio.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000121390018002656/f4030618green_aytubio.xml","form_type":"4"}},{"id":4110683,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":81127,"kind":"person","name":"Green David A","position":1,"cik":"0001372822","reported_name":"Green David A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T17:50:04.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted shares that vest on January 2, 2028, subject to earlier vesting in certain situations."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These are restricted shares that vest on January 2, 2028, subject to earlier vesting in certain situations."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These are restricted shares that vest on January 2, 2028, subject to earlier vesting in certain situations."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001213900-18-000085","document":"f4010218green_aytubioscience.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1372822/000121390018000085/f4010218green_aytubioscience.xml","form_type":"4"}}]}